Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-022217
Filing Date
2017-11-07
Accepted
2017-11-07 16:04:34
Documents
70
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nk-10q_20170930.htm 10-Q 2544130
2 EX-31.1 nk-ex311_6.htm EX-31.1 19649
3 EX-31.2 nk-ex312_7.htm EX-31.2 19611
4 EX-32.1 nk-ex321_8.htm EX-32.1 7011
5 EX-32.2 nk-ex322_9.htm EX-32.2 7046
  Complete submission text file 0001564590-17-022217.txt   9182274

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nk-20170930.xml EX-101.INS 2255798
7 XBRL TAXONOMY EXTENSION SCHEMA nk-20170930.xsd EX-101.SCH 55231
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nk-20170930_cal.xml EX-101.CAL 58136
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nk-20170930_def.xml EX-101.DEF 198581
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nk-20170930_lab.xml EX-101.LAB 408362
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nk-20170930_pre.xml EX-101.PRE 340883
Mailing Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121
Business Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 (858) 633-0300
NantKwest, Inc. (Filer) CIK: 0001326110 (see all company filings)

EIN.: 431979754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37507 | Film No.: 171183367
SIC: 2836 Biological Products, (No Diagnostic Substances)